CoChat

Effects of long-term treatment with Dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain

Open access

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

Purpose: The aim of this prospective study was to evaluate quality of life (QoL) and sexual function of women affected by endometriosis pain treated with Dienogest (DNG) for 24 months. Patients and methods: Fifty-four women constituted the study group and were given DNG 2 mg/daily; 38 women were given non-steroidal anti-inflammatory drugs (NSAIDs) and constituted the control group. To define endometriosis-associated pelvic pain, dysmenorrhea and dyspareunia the Visual Analogic Scale (VAS) was used. The Short Form-36 (SF-36), the Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale (FSDS) were used to assess the QoL, sexual function and the sexual distress, respectively. The study included five follow-ups at 3, 6, 12, 18 and 24 months. Results: Slight improvements in chronic pelvic pain, dysmenorrhea and dyspareunia were observed in the study group at 3 months ( p <0.05) and improved more from 6 to 24 months of DNG treatment ( p <0.001). QoL improved with a similar trend: at 3 months the improvement was significant in several categories ( p <0.05), and from 6 to 24 months in all categories ( p <0.001). The FSFI score did not change at the 3 month follow-up ( p =not significant [NS]) but it improved from 6 to 24 months ( p <0.001). A similar trend was observed for the FSDS score ( p <0.001). No change was observed in the control group ( p =NS). Conclusion: Long-term treatment with DNG 2 mg once-daily in women with endometriosis-associated pelvic pain may have positive effects on the QoL and sexual life, confirming the observations of the previous study on the first 6 months of treatment. Keywords: dyspareunia, endometriosis, chronic pelvic pain, long term dienogest, quality of life, sexual life

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/jpr.s207599

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Visual Analog Scale (VAS) score of women affected by endometriosis-associated chronic pelvic pain during treatment with Dienogest 2 mg/die. Abbreviation: NS, not significant.
Figure 1 Visual Analog Scale (VAS) score of women affected by endometriosis-associated chronic pelvic pain during treatment with Dienogest 2 mg/die. Abbreviation: NS, not significant.CC BY-NC · PubMed Central
Figure 2 Dysmenorrhea and dyspareunia of women with endometriosis-associated pelvic pain before and during treatment with Dienogest 2 mg/die (study group) and women using on-demand non-steroidal anti-inflammatory drugs (control group). Abbreviation: NS, not significant.
Figure 2 Dysmenorrhea and dyspareunia of women with endometriosis-associated pelvic pain before and during treatment with Dienogest 2 mg/die (study group) and women using on-demand non-steroidal anti-inflammatory drugs (control group). Abbreviation: NS, not significant.CC BY-NC · PubMed Central
Figure 3 Quality of life of women with endometriosis-associated pelvic pain before and during treatment with Dienogest 2 mg/die.
Figure 3 Quality of life of women with endometriosis-associated pelvic pain before and during treatment with Dienogest 2 mg/die.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 78

Metadata

Authors
Caruso, S., Iraci, M., Cianci, S., Vitale, S. G., Fava, V., & Cianci, A.
Affiliations
University of Catania (IT)
Corresponding author
Vitale, Salvatore Giovanni
Venue
Journal of Pain Research
Published
2019-07
Volume
Volume 12
Pages
2371-2378
ISSN
1178-7090 (ISSN-L)
OpenAlex
W2965687471
Cited by
73
References
37
Citations by year
2026: 6 · 2025: 5 · 2024: 10 · 2023: 10 · 2022: 9 · 2021: 18 · 2020: 14 · 2019: 1
FWCI
10.04
Type
journal article
Language
en
Open access
Locations
  • Journal of Pain Research (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
  • UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion, other-oa)
  • Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
Funders
Università di Catania
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
  • Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
Keywords
dienogest, endometriosis, chronic pelvic pain, dysmenorrhea, dyspareunia, quality of life, sexual function, sexual distress, long-term treatment, nonsteroidal anti-inflammatory drugs, progestogens

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of long-term treatment with Dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain. https://app.cochat.ai/papers/10.2147/jpr.s207599
The paper
Caruso, S., Iraci, M., Cianci, S., Vitale, S. G., Fava, V., & Cianci, A. (2019). Effects of long-term treatment with Dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain. Journal of Pain Research. https://doi.org/10.2147/jpr.s207599

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.